BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36530401)

  • 21. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients.
    Korpela T; Udd M; Mustonen H; Ristimäki A; Haglund C; Seppänen H; Kylänpää L
    Int J Cancer; 2020 Sep; 147(5):1450-1460. PubMed ID: 32162688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
    Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
    Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
    Knapen LM; van Dalem J; Keulemans YC; van Erp NP; Bazelier MT; De Bruin ML; Leufkens HG; Croes S; Neef C; de Vries F; Driessen JH
    Diabetes Obes Metab; 2016 Mar; 18(3):258-65. PubMed ID: 26537555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes.
    Chen ML; Wu CX; Zhang JB; Zhang H; Sun YD; Tian SL; Han JJ
    Front Endocrinol (Lausanne); 2022; 13():996228. PubMed ID: 36187118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
    Richter B; Hemmingsen B; Metzendorf MI; Takwoingi Y
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012661. PubMed ID: 30371961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
    Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.
    Min EK; Chong JU; Hwang HK; Pae SJ; Kang CM; Lee WJ
    World J Gastroenterol; 2017 Jan; 23(4):676-686. PubMed ID: 28216975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 Diabetes Mellitus and Non-Metastatic Colorectal Cancer: A Retrospective Study on Survival and Toxicity Profiles.
    Elabd NS; Alabassy MM; Seddik RM; Amer AA; Abdelaziz RA; Sohaib A
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):87-94. PubMed ID: 38285771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
    Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
    Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes.
    Binang HB; Perera CJ; Apte MV
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
    Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
    Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy.
    Tezuka K; Ohgi K; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Otsuka S; Todaka A; Uesaka K
    J Hepatobiliary Pancreat Sci; 2022 Aug; 29(8):922-931. PubMed ID: 35435311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    Tezuka K; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    J Gastroenterol; 2021 Jan; 56(1):101-113. PubMed ID: 33094352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis.
    Yao W; Meng Y; Lu M; Fan W; Huang J; Li J; Zhu Z
    Cancer Commun (Lond); 2018 Apr; 38(1):14. PubMed ID: 29764483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic Adenocarcinoma in Patients with Type 2 Diabetes: Prognosis and Survival.
    Turjoman MA; Alshaikh SF; Althobaiti AS; Yateem MA; Saifaddin ZK; AlFayea TM
    Cureus; 2020 Jul; 12(7):e9382. PubMed ID: 32850249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.